Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Patience

<< Previous

Bullboard Posts

Next >>

Comment by MoneyMouthon Mar 09, 2021 5:16pm

250 Views

Post# 32755640

RE:Patience

Reading over it again, there is significance that this is a collaborator presenting their findings. First, its a third party validating and vouching for SVA. Second, if these results are good, which they must be given the oral presentation and journal article, what sort of value does SVA subsequently have in this collaborators eyes? Was SVA the missing piece in whatever they have been working on? What's it worth to them?

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program